Cipla buys 60% stake in Sri Lankan co for $14m

Tags: Companies
Pharmaceutical firm Cipla Ltd today said it has acquired 60 per cent stake in a new company in Sri Lanka for $14 million (nearly Rs 85 crore) to market its product in the country.

Cipla (Mauritius) Ltd, a wholly owned subsidiary of the Indian company, has signed a definitive agreement with its existing Sri Lankan distributor for acquisition of 60 per cent stake in a new company, Cipla said in a filing to the BSE.

The new company will market the Cipla's products in Sri Lanka, it added.

"The consideration payable for the transaction is $14 million," the filing said, adding that the proposed acquisition was subject to regulatory approvals.

As part of its global expansion, Cipla has been active in acquisitions.

Last year, it completed the buyout of South African pharma firm Cipla Medpro for Rs 2,707 crore.

Cipla had also acquired Croatia-based firm Celeris, distributor of its products in that country last December.

Shares of Cipla were trading at Rs 411.30 per scrip in the afternoon trade, down 0.56 per cent from the previous close on the BSE.

EDITORIAL OF THE DAY

  • Acquiring indigenous capability to assemble and produce our own fighter aircraft is the goal

    Narendra Modi government’s decision to procure three squadrons totalling 36 Rafale combat aircraft from French Dassault Aviation through a bilateral

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Urs Schoettli

North Korea shakes up Manchuria

North Korea, officially the Democratic People’s Republic of Korea (DPRK), ...

Zehra Naqvi

Tree of life

Stories of trees that think, learn and speak are safely ...

Dharmendra Khandal

Let's leave bird songs to birds

The questions floating amongst wildlife enthusiasts these days are: Should ...